Stoke Therapeutics (STOK) Current Deferred Tax Assets (2024)
Stoke Therapeutics has reported Current Deferred Tax Assets over the past 1 years, most recently at $402000.0 for Q1 2024.
Stoke Therapeutics has reported Current Deferred Tax Assets over the past 1 years, most recently at $402000.0 for Q1 2024.